David Sutton

4.5k citations

76 papers · 2.6k indexed · h-index 24

Impact in

Equine top 1%
- Veterinary Equine Medical Research
Epidemiology top 2%
- Herpesvirus Infections and Treatments
- Cytomegalovirus and herpesvirus research

Papers in ⓘ

Epidemiology 24
- Herpesvirus Infections and Treatments 15
- Cytomegalovirus and herpesvirus research 10
- Trypanosoma species research and implications 6
Small Animals 16
- Helminth infection and control 8

Co-authors: M R Boyd (7 shared papers)T. H. Bacon (3 shared papers)Robert T. Sarisky (2 shared papers)Teresa H. Bacon (2 shared papers)Jeffry J. Leary (2 shared papers)Myron J. Levin (1 shared paper)Martin Cole (1 shared paper)R. Anthony Vere Hodge (4 shared papers)
Journals: Equine Veterinary Journal (10 papers)Antimicrobial Agents and Chemotherapy (5 papers)Journal of Equine Veterinary Science (4 papers)Journal of Medicinal Chemistry (4 papers)Molecular Cancer Therapeutics (4 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

David Sutton

70 papers receiving 2.5k citations

Peers

Countries citing papers authored by David Sutton

Since Specialization

Citations

This map shows the geographic impact of David Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sutton more than expected).

Fields of papers citing papers by David Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sutton. The network helps show where David Sutton may publish in the future.

Co-authors

The 25 scholars most cited alongside David Sutton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Sutton Line = papers co-authored together David Sutton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition Clinical Cancer Research ·Aidan G. Gilmartin, Maureen R. Bleam, Arthur Groy, Katherine G. Moss, Elisabeth A. Minthorn, Swarupa G. Kulkarni, Cynthia M. Rominger, Symon G. Erskine, Kelly E. Fisher, Jingsong Yang, Francesca Zappacosta, Roland S. Annan, David Sutton, Sylvie Laquerre	2011	459
2	Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy Clinical Microbiology Reviews ·Teresa H. Bacon, Myron J. Levin, Jeffry J. Leary, Robert T. Sarisky, David Sutton	2003	362
3	Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture Antimicrobial Agents and Chemotherapy ·M R Boyd, T. H. Bacon, David Sutton, Martin Cole	1987	205
4	Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir] Antimicrobial Agents and Chemotherapy ·R. Anthony Vere Hodge, David Sutton, M R Boyd, M. R. HARNDEN, Richard L. Jarvest	1989	158
5	Distinct Concentration-Dependent Effects of the Polo-like Kinase 1–Specific Inhibitor GSK461364A, Including Differential Effect on Apoptosis Cancer Research ·Aidan G. Gilmartin, Maureen R. Bleam, Mark C. Richter, Symon G. Erskine, Ryan G. Kruger, Lenore Madden, Daniel F. Hassler, Gary K. Smith, Richard R. Gontarek, Mary P. Courtney, David Sutton, Melody Diamond, Jeffrey R. Jackson, Sylvie Laquerre	2009	100
6	Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals Antimicrobial Agents and Chemotherapy ·M R Boyd, T. H. Bacon, David Sutton	1988	96
7	GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models Molecular Cancer Therapeutics ·Mary Ann Hardwicke, Catherine A. Oleykowski, Ramona Plant, Jamin Wang, Qiaoyin Liao, Katherine G. Moss, K. A. NEWLANDER, Jerry L. Adams, Dashyant Dhanak, Jingsong Yang, Zhihong Lai, David Sutton, Denis R. Patrick	2009	89
8	Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development Journal of Medicinal Chemistry ·Vincent Guerlavais, Tomi K. Sawyer, Luis A. Carvajal, Yong S. Chang, Bradford Graves, Jian-Guo Ren, David Sutton, Karen A. Olson, Kathryn Packman, Krzysztof Darłak, Carl Elkin, Eric Feyfant, Kamala Kesavan, Pranoti Gangurde, Lyubomir T. Vassilev, Huw M. Nash, Vojislav Vukovic, Manuel Aivado, D. Allen Annis	2023	79
9	Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties Journal of Medicinal Chemistry ·Michael R. Harnden, Richard L. Jarvest, Malcolm R. Boyd, David Sutton, R. Anthony Vere Hodge	1989	76
10	Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model Antimicrobial Agents and Chemotherapy ·Hugh J. Field, Deepanker Tewari, David Sutton, Alana M. Thackray	1995	64
11	Synthesis and antiviral activity of 9-alkoxypurines. 1. 9-(3-Hydroxypropoxy)- and 9-[3-hydroxy-2-(hydroxymethyl)propoxy]purines Journal of Medicinal Chemistry ·Michael R. Harnden, Paul G. Wyatt, Malcolm R. Boyd, David Sutton	1990	60
12	A Review of Methods for Assessment of the Rate of Gastric Emptying in the Dog and Cat: 1898–2002 Journal of Veterinary Internal Medicine ·Cathy Wyse, J. McLellan, A.M. Dickie, David Sutton, Thomas C. Preston, P.S. Yam	2003	52
13	Allodynia in rats infected with varicella zoster virus—a small animal model for post-herpetic neuralgia Brain Research Reviews ·Robert Dalziel, Sharon Bingham, David Sutton, D.A.D. Grant, Jean M. Champion, Shelley A Dennis, John P. Quinn, C. Bountra, M.A Mark	2004	52
14	The effects of xylazine, detomidine, acepromazine and butorphanol on equine solid phase gastric emptying rate Equine Veterinary Journal ·David Sutton, Tom Preston, Robert Christley, Noah D. Cohen, S. Love, A. J. Roussel	2002	50
15	Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16 Antimicrobial Agents and Chemotherapy ·David Sutton, M R Boyd	1993	49
16	First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models Breast Cancer Research ·Seyed Pairawan, Ming Zhao, Erkan Yuca, Allen Annis, Kurt W. Evans, David Sutton, Luis A. Carvajal, Jian-Guo Ren, Solimar Santiago, Vincent Guerlavais, Argun Akçakanat, Coya Tapia, Fei Yang, P. Bose, Xiaofeng Zheng, Ecaterina Ileana Dumbrava, Manuel Aivado, Funda Meric‐Bernstam	2021	48
17	Synthesis and in Vivo Evaluation of Prodrugs of 9-[2-(Phosphonomethoxy)ethoxy]adenine Journal of Medicinal Chemistry ·Halina T. Serafinowska, Ray J. Ashton, Stuart Bailey, Michael R. Harnden, Sally Jackson, David Sutton	1995	45
18	Effects of complex training versus heavy resistance training on neuromuscular adaptation, running economy and 5-km performance in well-trained distance runners PeerJ ·Fei Li, Ran Wang, Robert U. Newton, David Sutton, Yue Shi, Haiyong Ding	2019	45
19	Correlation of Eccentric Strength, Reactive Strength, and Leg Stiffness With Running Economy in Well-Trained Distance Runners The Journal of Strength and Conditioning Research ·Fei Li, Robert U. Newton, Yue Shi, David Sutton, Haiyong Ding	2019	44
20	Caecocaecal and caecocolic intussusceptions associated with larval cyathostomosis in four young horses Equine Veterinary Journal ·Tim Mair, David Sutton, S. Love	2000	39

About David Sutton

David Sutton is a scholar working on Epidemiology, Small Animals, Oncology, Molecular Biology and Equine, having authored 76 papers that have together received 2.6k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (15 papers), Veterinary Equine Medical Research (11 papers), Cytomegalovirus and herpesvirus research (10 papers), Cancer-related Molecular Pathways (8 papers), Helminth infection and control (8 papers), Microtubule and mitosis dynamics (7 papers), Vector-borne infectious diseases (6 papers) and Trypanosoma species research and implications (6 papers). The work is most often cited by research in Equine (125 citations), Epidemiology (997 citations), Parasitology (159 citations), Virology (115 citations) and Small Animals (172 citations). David Sutton has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include M R Boyd, T. H. Bacon, Robert T. Sarisky, Teresa H. Bacon, Jeffry J. Leary, Myron J. Levin, Martin Cole, R. Anthony Vere Hodge, Richard L. Jarvest and Aidan G. Gilmartin. Their work appears in journals such as Equine Veterinary Journal, Antimicrobial Agents and Chemotherapy, Journal of Equine Veterinary Science, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact